These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3320952)

  • 21. [Heparin-induced thrombopenia: significance and difficulties of precise identification of the immunologic mechanism].
    Samama MM; Elalamy I; Lecrubier C; Potevin F; Horellou MH; Conard J
    Bull Acad Natl Med; 1998; 182(7):1517-33; discussion 1534-6. PubMed ID: 9916345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adverse effects of drugs on blood formation. I].
    Libánský J
    Cas Lek Cesk; 1971 Feb; 110(8):183-8. PubMed ID: 5545533
    [No Abstract]   [Full Text] [Related]  

  • 23. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
    Fraunfelder FW; Richards AB
    Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis].
    Nakazaki S; Murayama T; Katoh S
    Ryumachi; 2001 Dec; 41(6):929-37. PubMed ID: 11831013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon.
    Ram R; Bonstein L; Gafter-Gvili A; Ben-Bassat I; Shpilberg O; Raanani P
    Am J Hematol; 2009 Apr; 84(4):247-50. PubMed ID: 19260124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diplopia and fluoroquinolones.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Agranulocytosis as a complication of acute infectious mononucleosis].
    Brkić S; Aleksić-Dordević M; Belić A; Jovanović J; Bogdanović M
    Med Pregl; 1998; 51(7-8):355-8. PubMed ID: 9769672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standardized assessment of drug-adverse reaction associations--rationale and experience.
    Venulet J; Ciucci A; Berneker GC
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):381-8. PubMed ID: 7450930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immuno-allergic cytopenias].
    Cheze S; Leporrier M
    Rev Prat; 2001 Sep; 51(14):1564-70. PubMed ID: 11757273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adverse effects of Disulone; results of the France pharmacovigilance inquiry. Regional Centers of Pharmacovigilance].
    Benedetti-Bardet C; Guy C; Boudignat O; Regnier-Zerbib A; Ollagnier M;
    Therapie; 2001; 56(3):295-9. PubMed ID: 11475811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy and granulocyte-colony stimulating factor for non-Hodgkin's lymphoma of the head and neck.
    Tsuge I; Suzuki K; Moribe K; Motai H; Kimura T; Umeda K; Kobayashi T; Yokota A; Hondo J; Baba S
    Acta Otolaryngol Suppl; 1996; 525():129-34. PubMed ID: 8908287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system.
    Tiaden JD; Wenzel E; Berthold HK; Müller-Oerlinghausen B
    Semin Thromb Hemost; 2005; 31(4):371-80. PubMed ID: 16149013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombopenia induced by heparin. From physiopathology to treatment].
    Gruel Y
    Ann Med Interne (Paris); 1997; 148(2):136-41. PubMed ID: 9238438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug-induced hiccup: a review of the France pharmacologic vigilance database].
    Bagheri H; Cismondo S; Montastruc JL
    Therapie; 1999; 54(1):35-9. PubMed ID: 10216420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New drugs: watch out for unexpected adverse effects.
    Prescrire Int; 2002 Oct; 11(61):150-1. PubMed ID: 12378747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse drug reactions as a cause for admissions to a department of internal medicine.
    Mjörndal T; Boman MD; Hägg S; Bäckström M; Wiholm BE; Wahlin A; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002; 11(1):65-72. PubMed ID: 11998554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993].
    Stricker BH; Ottervanger JP; van der Klauw MM
    Ned Tijdschr Geneeskd; 1994 Oct; 138(42):2110-3. PubMed ID: 7969579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.